189 related articles for article (PubMed ID: 10522486)
21. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation.
Rouas-Freiss N; Naji A; Durrbach A; Carosella ED
Transplantation; 2007 Jul; 84(1 Suppl):S21-5. PubMed ID: 17632407
[TBL] [Abstract][Full Text] [Related]
22. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:--a case report.
Trivedi HL; Mishra VV; Vanikar AV; Modi PR; Shah VR; Shah PR; Firoz A
Transplant Proc; 2006 Nov; 38(9):3103-8. PubMed ID: 17112910
[TBL] [Abstract][Full Text] [Related]
23. [Lymphocytes in transplantation immunity--in the relation to HLA antigens].
Takata H
Hum Cell; 1988 Sep; 1(3):275-81. PubMed ID: 2979204
[TBL] [Abstract][Full Text] [Related]
24. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT
Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393
[TBL] [Abstract][Full Text] [Related]
25. [Regeneration of the immune system after bone marrow transplantation].
Uher F; Puskás E; Torbágyi E; Barta A; Kormos L; Pálóczi K
Orv Hetil; 2001 Jan; 142(2):59-65. PubMed ID: 11209506
[TBL] [Abstract][Full Text] [Related]
26. The history and future prospective of haplo-identical stem cell transplantation.
Handgretinger R; Lang P
Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
[TBL] [Abstract][Full Text] [Related]
27. New approaches to the prevention of organ allograft rejection and tolerance induction.
Bagley J; Tian C; Iacomini J
Transplantation; 2007 Jul; 84(1 Suppl):S38-41. PubMed ID: 17632412
[TBL] [Abstract][Full Text] [Related]
28. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
[TBL] [Abstract][Full Text] [Related]
29. Immunobiology of rejection and adaptation.
Trivedi HL
Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
[TBL] [Abstract][Full Text] [Related]
30. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
31. The alloresponse.
Hernandez-Fuentes MP; Baker RJ; Lechler RI
Rev Immunogenet; 1999; 1(3):282-96. PubMed ID: 11256420
[TBL] [Abstract][Full Text] [Related]
32. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
33. Induction of xenotransplant tolerance.
Waer M; Ji P; Xia GL
Verh K Acad Geneeskd Belg; 2000; 62(2):137-51; discussion 152-3. PubMed ID: 10818821
[TBL] [Abstract][Full Text] [Related]
34. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
Pescovitz MD
Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
36. Natural killer T cells: a bridge to tolerance or a pathway to rejection?
Jukes JP; Wood KJ; Jones ND
Transplantation; 2007 Sep; 84(6):679-81. PubMed ID: 17893598
[TBL] [Abstract][Full Text] [Related]
37. Transplantation of a fetus with paternal Thy-1(+)CD34(+)cells for chronic granulomatous disease.
Muench MO; Rae J; Bárcena A; Leemhuis T; Farrell J; Humeau L; Maxwell-Wiggins JR; Capper J; Mychaliska GB; Albanese CT; Martin T; Tsukamoto A; Curnutte JT; Harrison MR
Bone Marrow Transplant; 2001 Feb; 27(4):355-64. PubMed ID: 11313664
[TBL] [Abstract][Full Text] [Related]
38. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
[TBL] [Abstract][Full Text] [Related]
39. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
[TBL] [Abstract][Full Text] [Related]
40. Immunobiology of solid organ transplantation.
Turvey SE; Wood KJ
Int Surg; 1999; 84(4):279-90. PubMed ID: 10667806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
